LEGAL STATUS — verified 10 Aug 2026: DEA notices of intent to temporarily Schedule I concentrated 7-OH (above threshold) and related analogues are published; no temporary scheduling order located yet — recheck the Federal Register before counseling.

About · contact

Brian Harris, MD

Board-certified in Addiction Medicine, Anesthesiology, and Sleep Medicine. Building a treatment bridge for concentrated 7-OH dependence.

Clinical consultation setting representing the treatment bridge
Evaluation, collegial consultation, and care coordination through EusomniaMD.

Clinical focus

Through EusomniaMD, Dr. Harris evaluates and treats kratom and concentrated 7-OH dependence and provides clinician-to-clinician consultation, treatment planning, lectures, and workflow development for outpatient practices, detoxification programs, and other settings. Patient coordination currently routes through eusomniamd.com.

Practice-based 7-OH experience

He reports directly treating a practice-based case series in the teens spanning botanical kratom and concentrated 7-OH dependence, plus informal consultation on dozens of additional 7-OH withdrawal cases. Patients have crossed age, sex, profession, and socioeconomic lines—including physicians. Retail purchase does not predict mild disease.

This experience informs the provisional timeline, milligram/interval emphasis, assessment beyond COWS, and risk-stratified pathways. It is unpublished, nonrandomized, not a prevalence sample, and not a comparative trial (evidence Grade D). Consultation cases are not counted as equivalent to longitudinally followed direct care.

Education

Faculty for the California Society of Addiction Medicine 2025 Addiction Medicine Board Exam Preparation Course (Basic Science / Neurobiology and Legal Aspects). Official course materials verify faculty roles; finer slide-level 7-OH teaching content is author-reported unless separately archived.

Services

Disclosures

Dr. Harris owns and operates EusomniaMD and may receive professional fees for clinical care, consultation, and speaking. No manufacturer, retailer, trade organization, law-enforcement agency, or advocacy group funded this resource. Educational material does not establish a clinician–patient relationship or provide legal advice.

Method & provenance

Publication controls and source notes: Appendix C. Full narrative: /full/. Protocols and appendices: downloads.

Contact

How to reach us

Choose the path that matches your request.

Patients & families

For evaluation or care coordination, contact the practice office via eusomniamd.com.

(650) 308-4845 · office@eusomniamd.com

Clinicians

Clinical framing lives behind the clinician door. For collegial case discussion after reviewing that material: bharris@eusomniamd.com.

Press, corrections & education

Media, corrections to this resource, and educational talks: bharris@eusomniamd.com.

SAMHSA Helpline: 1-800-662-HELP (4357) · Poison Help: 1-800-222-1222 · Brand home: eusomnia.org.